The use of NAMPT inhibitors (synthetic lethality) caused a severe metabolic crisis inducing the activation of AMPK, and autophagy-mediated cell death in glioma cells and in mice harboring intracranial IDH mutant glioma xenografts. The gene discussed is NAMPT; the disease is glioma.